Live Breaking News & Updates on Salt Creek Biosciences

Stay updated with breaking news from Salt creek biosciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Relmada Therapeutics Appoints Biopharmaceutical Marketing and Commercial Planning Veteran John Hixon as Head of Commercial

Relmada Therapeutics Appoints Biopharmaceutical Marketing and Commercial Planning Veteran John Hixon as Head of Commercial - read this article along with other careers information, tips and advice on BioSpace ....

United States , Coral Gables , University Of Miami Coral Gables , South Korea , John Hixon , Eli Lilly , Sergio Traversa , Tim Mccarthy , Reliance Clinical Research Program , Relmada Therapeutics Inc , Lilly Research Laboratories , Prnewswire Relmada Therapeutics Inc , Depauw University , Securities Exchange , Company Continues Commercial Preparations , Trial Readouts , Major Depressive Disorder Expected , Chief Executive Officer , Senior Director , Global New Product Planning , Salt Creek Biosciences , Relmada Therapeutics , Private Securities Litigation Reform Act , Securities Act , Securities Exchange Act , Elmada Therapeutics Appoints Biopharmaceutical Marketing And Commercial Planning Veteran John Hixon As Head Of ,

Relmada Therapeutics Appoints Biopharmaceutical Marketing and Commercial Planning Veteran John Hixon as Head of Commercial

/PRNewswire/ Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today. ....

United States , Coral Gables , University Of Miami Coral Gables , South Korea , John Hixon , Eli Lilly , Sergio Traversa , Tim Mccarthy , Reliance Clinical Research Program , Relmada Therapeutics Inc , Lilly Research Laboratories , Prnewswire Relmada Therapeutics Inc , Depauw University , Securities Exchange , Company Continues Commercial Preparations , Trial Readouts , Major Depressive Disorder Expected , Chief Executive Officer , Senior Director , Global New Product Planning , Salt Creek Biosciences , Relmada Therapeutics , Private Securities Litigation Reform Act , Securities Act , Securities Exchange Act ,